MTN-026

A Phase I study that evaluated whether a gel containing dapivirine is safe for use in the rectum. The study will help determine whether further testing on the safety and acceptability of dapivirine gel as a potential rectal microbicide can be conducted in a larger population.  Results are anticipated in late 2019.

 

MTN-026 Backgrounder

30-October-2017

 

MTN-026 Q&A

30-October-2017

 

See Also

MTN-026 Protocol

 

MTN-026 Study Page

 

Rectal Microbicides - Fact Sheet

17-July-2018


Source URL: https://mtnstopshiv.org/news/studies/mtn026